FDA Issues Policies to Guide COVID-19 Treatment Development On February 22, 2021 the FDA released two guidances regarding the development of COVID-19 drugs. The first guidance specifically deals with the development of monoclonal antibody products, while the second guidance is focused on drugs that treat or prevent COVID-19. These guidances contain non-binding recommendations for sponsors
Back in December the FDA released a Federal Register Notice announcing the fees for OTC Drug Manufacturing facilities. Since then, the FDA has withdrawn the FRN. Originally, through the OMUFA webpage, it is stated that “[T]he Department clarifies that persons that were not registered with FDA as drug manufacturers prior to the COVID-19 Public Health
Coronavirus (COVID-19) Update: FDA Takes Action to Place All Alcohol-Based Hand Sanitizers from Mexico on Import Alert to Help Prevent Entry of Violative and Potentially Dangerous Products into US to Protect U.S. Consumers The FDA has just enacted a countrywide product alert on hand sanitizers being imported from Mexico. Many of these products appear to
FDA Update New devices added to the device discontinuance list. The FDA is constantly reviewing their emergency use list. As we have been writing and warning that as the amount of needed products come to market via the EUA and 510(k) the FDA will discontinue the items. Companies should be away that they will need
Since the beginning of the pandemic, the FDA has been in observation of reports of serious adverse events related to ingestion of alcohol-based hand sanitizers. The FDA has also received numerous reports of dermal toxicity associated with these products. In the Spring 2020, FDA discovered a few hand sanitizer products that were labeled to contain
Over the past 10 months mdi has been actively assisting numerous companies with the EUAs for Masks, Gowns and Gloves as well as the Covid 19 tests. Several of our clients are included in the numbers provided by the FDA below. To look back on 2020, the FDA has released an infographic providing visualization of
The FDA is warning consumers not to use close to 50 male enhancement or weight loss products. These products have been found to contain hidden ingredients and may pose health risks. Products were purchased by the FDA through Amazon and eBay and testing found active pharmaceutical ingredients not included on the label. Some of these
We have been warning clients on the use of CBD and the FDA regulatory requirements. You need to be very careful on the claims you want to make on your products that contain CBDs. Here is some recent FDA actions. The FDA has recently issues 5 warning letters to companies for violating Federal Food, Drug,
REMINDER FDA Update – Human and Animal Food Facilities Biennial Registration Renewal The FDA is reminding human and animal food facilities about this year’s biennial registration renewal period. These facilities, domestic and foreign, are that required to register with the U.S. FDA must renew their registration this year before December 31. The FDA will consider
The FDA has issued the guidance document, Conduct of Clinical Trials of Medical Products During COVID-19 Public Health Emergency, because the agency recognizes that the public health emergency caused by COVID-19 has impacted the conduct of clinical trials of medical products, including drugs, devices, and biologics. These challenges may arise from isolation practices, site closures,
mdi Consultants, Inc